Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non--ST-Segment Elevation Acute Coronary Syndromes.

Presents a study to systematically evaluate the end points of all-cause death and nonfatal myocardial infarction, transfusion, and major bleeding observed in the 6 randomized controlled trials comparing enoxaparin and unfractionated heparin in treatment of acute coronary syndromes. Description of the study and its results; Conclusion.